Published in Scand J Public Health on July 05, 2011
A decade of molecular genetic testing for MODY: a retrospective study of utilization in The Netherlands. Eur J Hum Genet (2014) 0.76
A model of care for familial hypercholesterolaemia: key role for clinical biochemistry. Clin Biochem Rev (2012) 0.75
Translating genetics beyond bench and bedside: A comparative perspective on health care infrastructures for 'familial' breast cancer. Appl Transl Genom (2016) 0.75
A ferry between cultures. Crafting a new profession at the intersection of science and society. EMBO Rep (2008) 2.43
Evidence-based medicine and power shifts in health care systems. Health Care Anal (2002) 1.52
Bio-objects' political capacity: a research agenda. Croat Med J (2013) 1.35
European practices of genetic information and insurance: lessons for the Genetic Information Nondiscrimination Act. JAMA (2008) 1.16
Constructing "best interests": genetic testing of children in families with hypertrophic cardiomyopathy. Am J Med Genet A (2011) 0.96
Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts. Eur J Hum Genet (2012) 0.92
Sensitization: reciprocity and reflection in scientific practice. Science & Society Series on Convergence Research. EMBO Rep (2009) 0.91
Making genetics not so important: family work in dealing with familial hypertrophic cardiomyopathy. Soc Sci Med (2010) 0.87
Genetic 'risk carriers' and lifestyle 'risk takers'. Which risks deserve our legal protection in insurance? Health Care Anal (2007) 0.87
Reflections on different governance styles in regulating science: a contribution to 'Responsible Research and Innovation'. Life Sci Soc Policy (2015) 0.84
The 'empowered client' in vocational rehabilitation: the excluding impact of inclusive strategies. Health Care Anal (2012) 0.82
Providing preimplantation genetic diagnosis in the United Kingdom, The Netherlands and Germany: a comparative in-depth analysis of health-care access. Hum Reprod (2009) 0.81
Nicotine vaccination--does it have a future? Addiction (2014) 0.79
Constructing access in predictive medicine. Comparing classification for hereditary breast cancer risks in England, Germany and the Netherlands. Soc Sci Med (2010) 0.78
Vaccination against smoking: an annotated agenda for debate. A review of scientific journals, 2001-13. Addiction (2014) 0.76
Engineering flesh: towards an ethics of lived integrity. Med Health Care Philos (2008) 0.76
'Genetics is not the issue': insurers on genetics and life insurance. New Genet Soc (2005) 0.75
Voice beyond choice: hesitant voice in public debates about genetics in health care. Health Care Anal (2003) 0.75
How political cultures affect governance efforts to protect "posted genes": insights from Germany. Am J Bioeth (2014) 0.75
Proper science in moist biology. EMBO Rep (2007) 0.75
Research in the wild. Nature (2007) 0.75
Lessons from the Netherlands for the health and social care bill. Lancet (2011) 0.75
A question of style: method, integrity and the meaning of proper science. Endeavour (2009) 0.75
Making the normal deviant: the introduction of predictive medicine in life insurance. Soc Sci Med (2006) 0.75
Disembodied abilities: sick role and participation in 'activating' return-to-work practices. Soc Sci Med (2013) 0.75
A sociological perspective on "the unmotivated client": public accountability and professional work methods in vocational rehabilitation. Disabil Rehabil (2012) 0.75
How can we assess the value of complex medical innovations in practice? Expert Rev Pharmacoecon Outcomes Res (2015) 0.75
Contested evidence: a Dutch reimbursement decision taken to court - CORRIGENDUM. Health Econ Policy Law (2017) 0.75
Side effects of problem-solving strategies in large-scale nutrition science: towards a diversification of health. Br J Nutr (2009) 0.75